CANCER SUPPORT
1300 881 698
CANCER SUPPORT | 1300 881 698
Cancer and Religious Fasting
Samantha Spokes
We spoke to Senior Oncology Dietitian, Lauren Atkins, and pancreatic cancer patient, Aida, for their thoughts on how to navigate religious fasting periods if you or a loved one is impacted by
New PBAC application supports immunotherapy treatment for oesophageal and gastro-oesophageal junction cancers
Nikki Rynia
Pancare is supporting Bristol Meyers Squibb in their application to the Pharmaceutical Benefits Advisory Committee (PBAC) for the funding of Nivolumab, an immunotherapy for the treatment of
How to safely access polling booths and vote if you are unwell
With the 2022 federal election around the corner, we want to help our patients and carers understand how they can participate in voting safely whether they are well or unwell, at home or in a health
Advocating for upper GI cancers: oesophageal and gastric cancer update
An important part of Pancare supporting patients with upper gastrointestinal (GI) cancers is advocating for better treatment and unmet needs.
Recent study supports use of second line chemotherapy combined with active symptom control (ASC) for the treatment of advanced biliary tract cancer.
Patients with advanced biliary tract cancer receiving second-line FOLFOX chemotherapy and active symptom control (ASC) are more than twice as likely to be alive at 12 months compared to those on ASC
Trial of radiation implant extends the life of metal biliary stents
New radiation implant trial has important implications for the prevention of jaundice in liver and pancreatic cancer.
Positive results for checkpoint inhibitor therapy in people with oesophageal cancer post-surgery
New study shows positive results for checkpoint inhibitor therapy in people with oesophageal or oesophagogastric junctional cancer post-surgery
Is there a role for laparoscopic surgery for resection of pancreatic head and neck cancers in Australia?
This recent trial compared 300 patients undergoing laparoscopic vs. 300 patients undergoing open pancreas cancer surgery. Results showed that patients treated with keyhole surgery went home 1 day
New study examines different approaches for selective internal radiation therapy (SIRT) for advanced liver cancer
This recent phase 2 trial examined the effects of personalised dositometry versus standard dositometry of selective internal radiation therapy (SIRT) for treatment of unresectable locally-advanced
